Resource and Data Exchange - Health Research | UVA | Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States

Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction, United States

Dataset Files: No dataset files have been uploaded to this dataset.

Monthly Cumulative Number and Percent of Children <20 Months Who Received Nirsevimab by Age Group and Jurisdiction • Estimated nirsevimab coverage for children 0-19 months is assessed through U.S. jurisdictions’ Immunization Information Systems [IIS] data, submitted from jurisdictions to CDC monthly in aggregate by age group. • Starting in July 2023, the CDC recommended the RSV vaccine to protect against serious illness from RSV. [https://www.cdc.gov/respiratory-viruses/whats-new/rsv-update-2023-09-22.html]

Dataset Type	Generic
Keywords	rsv vaccination, iis, immunization information system
Primary Associated Project	Vaccinations Datasets CDC
Storage Organization	University of Virginia
HIPAA Identifiers	N/A: Not derived from Medical Records
Data Granularity	NONE
Other Sensitive Data	NONE
Link to External Dataset File	https://data.cdc.gov/d/ku7p-zn4c